Children's Hospital Medical Center, Cincinnati

This study tested whether a natural sugar called 2'-fucosyllactose (2FL) is safe and helpful for people receiving a bone marrow transplant. The goal was to see if it could improve gut health, reduce harmful bacteria, and lower the risk of infections and graft-versus-host disease.…

This study tested a program called HALO for children aged 6-12 whose mothers had weight-loss surgery. The program helped kids learn healthier eating and activity habits. 35 families took part to see if the program could help children maintain a healthy weight.

This study tested a drug called dupilumab in 41 people aged 12 to 70 with eosinophilic gastritis, a condition where certain white blood cells build up in the stomach and cause pain and swelling. Participants received injections of dupilumab or a placebo every two weeks for 12 wee…

This study looked at how to improve testing for sexually transmitted infections (STIs) like gonorrhea and chlamydia in teenagers visiting emergency departments. Researchers compared two methods: testing only teens with certain risk factors versus offering testing to everyone. The…

This study tested a special toothpaste containing tacrolimus to help manage painful mouth sores caused by chronic graft-versus-host disease (cGVHD) after a stem cell transplant. Seven patients aged 1 to 40 used the toothpaste alongside their regular medicines. The goal was to see…

This study tested a new program designed to help teens and young adults (ages 15-24) with cancer take their oral chemotherapy or preventive medications as prescribed. 70 participants were randomly assigned to either the tailored program or standard care. The main goal was to see …

This study tested a telehealth program called GET2HOME for children with complex chronic conditions leaving the hospital. The goal was to see if the program could reduce unplanned hospital visits and improve quality of life for the child and family. Over 600 children and their fa…

This study involved 8 children and teens with cystic fibrosis who had a history of MRSA infection and were receiving the antibiotic ceftaroline. Researchers measured drug levels in the blood to see if current dosing recommendations work well for this group. The goal was to gather…